Survival Outcomes in Patients With mRCC Receiving Immune Checkpoint Inhibitor Therapy With or Without Cytoreductive Nephrectomy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: